Therapeutic category of drugs in Japan [BR:br08301]
3 Agents affecting metabolism
39 Other agents affecting metabolism
396 Antidiabetic agents
3969 Others
D10179 Trelagliptin succinate (JAN/USAN)
Drug groups [BR:br08330]
Antidiabetic agent
DG02044 Hypoglycemic agent
DG01601 DPP-4 inhibitor
DG01284 Trelagliptin
D10179 Trelagliptin succinate
Metabolizing enzyme substrate
DG01644 CYP2D6 substrate
DG01284 Trelagliptin
D10179 Trelagliptin succinate
Drug classes [BR:br08332]
Antidiabetic agent
DG01601 DPP-4 inhibitor
D10179 Trelagliptin succinate
DG02044 Hypoglycemic agent
D10179 Trelagliptin succinate
Target-based classification of drugs [BR:br08310]
Peptidases and inhibitors
Serine peptidases
Prolyl oligopeptidase family
DPP4 (CD26)
D10179 Trelagliptin succinate (JAN/USAN) <JP>
New drug approvals in Japan [br08318.html]
Drugs with new active ingredients
D10179
New drug approvals in the USA, Europe and Japan [br08328.html]
Approval dates by FDA, EMA and PMDA
D10179
Drug metabolizing enzymes and transporters [br08309.html]
Drug metabolizing enzymes
D10179
Drug groups [BR:br08330]
Antidiabetic agent
DG02044 Hypoglycemic agent
DG01601 DPP-4 inhibitor
DG01284 Trelagliptin
Metabolizing enzyme substrate
DG01644 CYP2D6 substrate
DG01284 Trelagliptin